Cellosaurus logo
expasy logo

Cellosaurus RAL (CVCL_WH09)

[Text version]
Cell line name RAL
Accession CVCL_WH09
Resource Identification Initiative To cite this cell line use: RAL (RRID:CVCL_WH09)
Comments Doubling time: ~65 hours (PubMed=9809028).
Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
Sequence variations
Disease Lung adenocarcinoma (NCIt: C3512)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Female
Age at sampling 52Y
Category Cancer cell line
Publications

PubMed=9809028; DOI=10.1016/S0165-4608(98)00076-4
Gasperi-Campani A., Roncuzzi L., Ricotti L., Lenzi L., Gruppioni R., Sensi A., Zini N., Zoli W., Amadori D.
Molecular and biological features of two new human squamous and adenocarcinoma of the lung cell lines.
Cancer Genet. Cytogenet. 107:11-20(1998)

PubMed=10574245; DOI=10.1038/sj.bjc.6690737; PMCID=PMC2362882
Zoli W., Ricotti L., Dal Susino M., Barzanti F., Frassineti G.L., Folli S., Tesei A., Bacci F., Amadori D.
Docetaxel and gemcitabine activity in NSCLC cell lines and in primary cultures from human lung cancer.
Br. J. Cancer 81:609-615(1999)

PubMed=10841287
Calistri D., Barzanti F., Dal Susino M., Fedriga R., Saragoni L., Bernardi L., Ricotti L., Zoli W.
Correlation between p53 gene mutations and p53 protein accumulation evaluated by different methodologies.
J. Biol. Regul. Homeost. Agents 14:120-127(2000)

PubMed=26919099; DOI=10.18632/oncotarget.7575; PMCID=PMC4951299
Arienti C., Zanoni M., Pignatta S., Del Rio A., Carloni S., Tebaldi M., Tedaldi G., Tesei A.
Preclinical evidence of multiple mechanisms underlying trastuzumab resistance in gastric cancer.
Oncotarget 7:18424-18439(2016)

Cross-references
Cell line databases/resources cancercelllines; CVCL_WH09
Encyclopedic resources Wikidata; Q98128798
Polymorphism and mutation databases IARC_TP53; 9935
Entry history
Entry creation24-May-2019
Last entry update19-Dec-2024
Version number8